AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie long-Term Debt and Finance Lease Obligations, Noncurrent ($M) ($M)
Form 10-Q / 10-K Consolidated Balance Sheets & Debt Note
Latest, FY2025
58,941
Period ended Dec 31, 2025
Change on a year earlier
-2.3%
60,340 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Long-Term Debt and Finance Lease Obligations, Noncurrent ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 58,941 | -2.3% | Form 10-Q (filed 2026-08-03) ↗ |
| FY2024 | Dec 31, 2024 | 60,340 | +15.6% | Form 10-K (filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 52,194 | -11.7% | Form 10-K (filed 2025-02-14) ↗ |
| FY2022 | Dec 31, 2022 | 59,135 | -7.9% | Form 10-K (filed 2024-02-20) ↗ |
| FY2021 | Dec 31, 2021 | 64,189 | -17.2% | Form 10-K (filed 2023-02-17) ↗ |
| FY2020 | Dec 31, 2020 | 77,554 | +23.2% | Form 10-K (filed 2022-02-18) ↗ |
| FY2019 | Dec 31, 2019 | 62,975 | +79.9% | Form 10-K (filed 2021-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 35,002 | +13.1% | Form 10-K (filed 2020-02-21) ↗ |
| FY2017 | Dec 31, 2017 | 30,953 | -15.1% | Form 10-K (filed 2019-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 36,440 | +24.6% | Form 10-K (filed 2018-02-16) ↗ |
| FY2015 | Dec 31, 2015 | 29,240 | – | Form 10-K (filed 2017-02-17) ↗ |
Breakdown
What makes up long-term debt and finance lease obligations, noncurrent ($m)
- Current Portion of Long-Term Debt and Finance Leases ($M)6,056 · FY2025
- Short-Term Borrowings ($M)2,499 · FY2025
- Cash Paid for Interest [annual] ($M)3,002 · FY2025
- Long-Term Debt Maturities — Year 1 ($M)6,000 · FY2025
- Long-Term Debt Maturities — Year 2 ($M)5,130 · FY2025
- Long-Term Debt Maturities — Year 3 ($M)4,466 · FY2025
- Long-Term Debt Maturities — Year 4 ($M)8,645 · FY2025
- Long-Term Debt Maturities — Year 5 ($M)1,000 · FY2025
- Long-Term Debt Maturities — After Year 5 ($M)39,262 · FY2025
Cite this data
StockData. (2026). AbbVie Long-Term Debt and Finance Lease Obligations, Noncurrent ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/debt_lt_nc
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.